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Abstract 
 
Specially designed transcutaneous electrical stimulation paradigms can be used to provoke experimental itch. 
However, it is unclear which primary afferent fibers are activated and whether they represent pathophysiologically 
relevant, C-fiber mediated itch. Since low-threshold mechano-receptors have recently been implicated in 
pruriception we aimed to characterize the peripheral primary afferent subpopulation conveying electrically evoked 
itch in humans (50 Hz stimulation, 100 μs square pulses, stimulus-response function to graded stimulus intensity). In 
10 healthy volunteers a placebo-controlled, 24-hour, 8% topical capsaicin-induced defunctionalization of capsaicin-
sensitive (transient receptor potential V1-positive, ‘TRPV1+’) cutaneous fibers was performed. Histaminergic itch 
(1% solution introduced by a skin prick test lancet) was provoked as a positive control condition. Profound losses of 
warmth and heat pain sensitivity (pain threshold and supra-threshold ratings) as assessed by quantitative sensory 
testing, were found as indicative for efficient TRPV1-fiber defunctionalization (all outcomes: P <0.0001). The 
topical capsaicin profoundly, and with equal efficaciousness, inhibited itch intensity evoked by electrical stimulation 
and histamine (-89 ± 4.1% and -78% ±4.9%, respectively, both: P <0.0001 compared to the placebo patch area). The 
predominant primary afferent substrate for electrically evoked itch in humans, using the presently applied 
stimulation paradigm, is concluded to be capsaicin-sensitive polymodal C-fibers.   





Itch in both experimental and clinical itch studies is frequently elicited by various transcutaneous electrical 
stimulation paradigms [1–6]. These method has been used to document increased itch sensitivity in chronic itch 
patients [5–7] and allow for temporal control and customization of the stimulation intensity, opposite to the more 
thoroughly investigated chemical itch models [8]. On the other hand electrical stimulation is non-selective, 
unphysiological, and it is unclear which primary afferent fibers that are involved in conveying electrically elicited 
itch [1,2]. Notably, electrical stimulation often produces co-sensations such as tapping, buzzing or tingling, 
generally associated with activity of large myelinated primary afferents. Recently, low-threshold mechano-receptors 
(LTMRs), i.e. C-tactile and Aβ-fibers, have been implicated in mechanically evoked itch in response to stimuli that 
are probably below the threshold of pruriceptive nociceptors [9,10]. This prompts reconsideration as to whether 
electrically evoked itch paradigms actually probes the afferent units that are spontaneously active and sensitized in 
patients with chronic itch or whether an entirely different pathway is activated. In humans prolonged topical 
application of high-concentration capsaicin can profoundly defunctionalize dermo-epidermal nociceptive fibers 
expressing transient receptor potential V1 channel (TRPV1) [11], and has previously been shown to almost entirely 
inhibit warmth/heat pain sensations as well as itch evoked by activation of both C-mechano-insensitive 
(histaminergic) and polymodal C-fibers (cowhage-induced) [12]. In the present double-blinded, placebo-controlled, 
cross-over study such an ablation of capsaicin-sensitive dermo-epidermal C- and Aδ-fibers in human skin 
performed, validated by psychophysical warmth/heat pain assessments. Subsequently, electrically evoked itch 
sensitivity was tested in the capsaicin/placebo-pretreated areas and histaminergic itch was used as a positive control.  
 
 
2. Materials and methods  
 
Ten healthy male volunteers were enrolled (23.6 years, range 21-25). The local ethics committee approved the 
protocol (N-20160026). Subjects were informed about the procedures involved in the study and gave their written 
informed consent prior to the experiment. The study consisted of three sessions and lasted approximately 2.5 hours 
in total. The first session was a screening where the electrical paradigm was tested and non-responders were 
excluded; defined as a peak itch of <20 (VAS0-100), prompting N=3 exclusions. Then capsaicin and placebo patches 
were applied for 24 hours and removed (session two). In the third session, 24 hours after patch removal the sensory 
tests were conducted in both the placebo and capsaicin-treated area. 
 
2.1. Capsaicin-induced fiber ablation: Two 4x4cm areas, 3 cm apart, on the medial aspect of the volar forearm 
were pretreated with either an 8% capsaicin patch (Qutenza®, Grüenthal, Germany) or a placebo patch for 24 hours. 
Distal versus proximal application sites were randomized in a balanced manner. The application of additional 
opaque occlusion was utilized to blind the subjects (taking advantage of the poor localizability of chemo-nociceptive 
stimuli) and to blind the investigators performing the psychophysiological tests. 24 hours after patch removal the test 
session was performed. This technique has previously been used to study the skin under capsaicin-sensitive fiber 
depleted conditions [11,12].  
 
2.2. Validation of capsaicin-induced fiber ablation: A 3x3cm thermal probe was attached to the 4x4cm patch 
application skin areas. The probe was connected to a Pathway sensory stimulator (Medoc, Ramat Yishai, Israel), 
controlled by Medoc Main Station software. The baseline temperature was always 32˚C and for warmth detection 
and heat pain threshold (‘WDT’ and ‘HPT’, respectively) ramping stimuli of 1˚C/s were delivered until the subjects 
identified the associated threshold (first perception warmth and first perception heat pain) by pressing a stop button. 
Hereafter the temperature returned to 32˚C, at a rate of 1˚C/s. WDT and HPT were performed in triplicates and 
averaged. Suprathreshold heat pain sensitivity (SHPS) was assessed by two ramps-and-hold stimuli lasting 1s at 
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50˚C with ascending and descending ramp rates of 5˚C/s. Subjects rated each evoked stimulus on a numerical rating 
scale from 0=’no pain’ to 10=’worst imaginable pain’.  
 
2.3 Electrically evoked itch stimulus-response function: Two surface electrodes were attached 2 cm apart within 
the pretreated 4x4 cm. Ramp stimuli were applied at 50Hz with a pulse duration of 100μs, using an increasing 
current intensity (0.05 mA/s). Current intensity started at 0.4 mA and ended at 6.4 mA (2-minute duration per 
stimulus ramp). This stimulation paradigm is described in details elsewhere [2,4]. The stimulus-response curve was 
constructed by simultaneous ratings of itch intensity obtained using a 100-mm digital visual analog scale (VAS) on a 
tablet: ‘no itch’=0 mm, and ‘worst imaginable itch’=100-mm. Itch intensity ratings were conducted continuously 
and sampled at 0.2Hz. 
 
2.4. Histamine evoked itch: Histamine dihydrochloride 1% solution (Allergopharma, Germany) was applied using 
a 1-mm shouldered skin prick test (SPT) lancet. A drop was placed in the center of the placebo or capsaicin-
pretreated area and pricked with the SPT lancet using a 120g weighted device (Aalborg University, Denmark) as 
previously described [13]. Immediately hereafter a 10-minute VAS-recording of the itch intensity was initiated using 
the same approach as described for electrically evoked itch.  
 
2.5. Statistics: Analyses were performed with SPSS 25 (IBM, Armonk, USA). The studentized residuals for all 
variables were normally distributed according to Shapiro-Wilks test. Thermal validation tests were assessed using 
paired-samples t-tests. The main outcome of itch following capsaicin/placebo pretreatment was assessed by two-way 
RM-ANOVAs with two factors: treatment (levels: capsaicin and placebo) and provocation method (levels: electrical 





3.1. Validation of capsaicin-induced ablation: The 8% capsaicin ablation induced significant sensory 
desensitization to warmth, heat pain and suprathreshold heat stimuli (lowest t9=7.1; all outcomes:  P <0.0001, Fig. 
1A-C). As an example, pain in response to a short 50˚C heat pulse was reduced from 7.7±0.3 (NRS0-10) in the 
placebo-treated area to only 1.7±0.3 in the capsaicin-treated area.  
 
3.2. Itch inhibition: The capsaicin-induced fiber ablation inhibited histamine- and electrically evoked itch to the 
same extent (Fig. 2A-C). The RM-ANOVAs for both peak and mean showed a profound capsaicin-mediated 
inhibition of itch evident from the main effect of treatment (F1,9 = 63.3, P<0.0001; mean itch and F1,9 = 65.5, 
P<0.0001; peak itch). Both for mean and peak itch there were no main effect of provocation method (lowest test F-
value: F1,9 = 2.5, P=0.15; peak itch) signifying that histamine and the electrical stimulation evoked comparable itch 
intensities. The treatment x provocation interaction was also insignificant demonstrating that the capsaicin-ablation 
equally inhibited electrical and histamine-evoked itch (lowest test F-value: F1,9 = 2.2, P=0.18; peak itch, Fig. 2C). It 
was noted that the histamine provocations, but never the electrical stimulation procedure, produced wheal and flare 
reactions in all subjects. Histamine-evoked flares were significantly smaller in capsaicin pre-treated skin (data not 
shown) as indicative for inhibition of neurogenic inflammation.  
 
 
4. Discussion  
 
Defunctionalization of capsaicin-sensitive fibers in human skin inhibited itch evoked by electrical itch stimulation 
paradigm and histamine with equal efficacy. The applied capsaicin ablation approach generally targets subsets of 
Aδ- and C-fibers expressing TRPV1+, while leaving C-tactile and Aβ-fibers fibers intact since these are TRPV1-
negative. Under these conditions histaminergic itch receptiveness is as expected almost entirely inhibited. This is 
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aligned with studies suggesting that this pathway relies on C-mechano-insensitive TRPV1+ fibers [12,14,15]. The 
fact that cowhage-induced itch is also highly susceptible to inhibition by capsaicin pretreatment suggests that most 
polymodal C-fibers are also TRPV1+, and this thus represent a commonality between the two most well-elucidated 
human primary afferent pathway of itch [12].  
 
The electrically induced itch was effectively inhibited, thus suggesting that this sensation is primarily mediated by 
TRPV1+ C- and possibly, Aδ-fibers. A hallmark of C-mechano-insensitive fiber activation is the neurogenic flare 
response [16], which was never observed after the electrical stimulation. Hence, these units are unlikely to be 
involved in transmission of itch in the present stimulation paradigm. Moreover, C-tactile and Aβ units can be 
excluded because these are unresponsive to the capsaicin-ablation [11] and thus would have left a much more intact 
itch response to the presently applied electrical stimulation. This in turn leaves polymodal C-fibers as the likeliest 
candidate, which corroborates and extends on an earlier finding by Mochizuki et al. (2008) based on conduction 
velocity data from EEG-recorded sensory evoked potentials also pointing towards C-fibers as a whole [17].  
 
The purported itch-conveying Mas-related G-protein receptor D (MrgprD)-subset of non-peptidergic nociceptors is 
known to terminate very superficially in the epidermis and do not significantly co-express TRPV1 [18–20]. 
Consequently, it can be inferred that these fibers either do not transmit electrically evoked itch of the present 
stimulation paradigm or that they are inadvertently defunctionalized by the capsaicin-treatment. Further studies 
using itch provocations with β-alanine (an MrgprD-agonist) following a topical capsaicin-ablation could clarify this. 
In this context, general caution have to be considered with regards to the specificity, fiber subpopulation 
preferentially and effectiveness of the 8% capsaicin ablation technique, which remains to be fully elucidated [11]. It 
should be noted that while the sensory effects of the present capsaicin pretreatment are pronounced, it does not 
represent a complete loss as demonstrated particularly by both the conservation of some degree of heat sensitivity as 
well as the mild itch response to histamine in a few subjects. Moreover, the high stimulation frequency (≥50 Hz, 
short duration stimuli [1,2]) required is nominally against the notion of C-nociceptors as the substrate for electrically 
evoked itch because it is significantly above the natural instantaneous frequency of the majority of such units. 
Lastly, this study does not refute that the recently highlighted pruriceptive LTMRs [9,10] are present in hairy human 
skin but simply demonstrate that they are not the predominant substrate for the presently applied electrical itch 





In conclusion, we suggest that electrically induced itch (evoked by a unique stimulation paradigm) is conveyed 
predominantly by capsaicin sensitive (TRPV1+) polymodal C-fibers similarly to the fibers activated by some 
chemical itch provocation models, e.g. cowhage. This primary afferent subpopulation is also implicated in itch and 
sensitization for itch in chronic pruritic clinical conditions [21]. Moreover, besides targeting a relevant fiber 
population the temporal controllability of electrical itch induction techniques enables neuroimaging methods and 
studies on rapid pruriceptive modulation processes where repeated controlled itch provocations can be applied (e.g. 
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Figure legend 
 
Figure 1: A, B and C) Validation of capsaicin-induced sensory desensitization. Individual subject (grey dots) and 
mean (red dots) increase in warmth detection threshold (A), heat pain threshold (B) and suprathreshold heat pain 
sensitivity (C). Cap = capsaicin. N = 10 for all plots. Error bars represents standard error of mean, *** = P < 0.0001. 
 
Figure 2: A) Histamine evoked itch intensity in capsaicin (red dots) versus placebo (grey dots) treated skin areas. 
Dashed lines represent the overall mean itch intensities. B) Electrically evoked itch in capsaicin (red dots) versus 
placebo (grey dots) treated skin areas. Dashed lines represent the overall mean itch intensities. C) Similar 
percentage-wise itch reduction observed for the histamine provocation and the electrical stimulation paradigm. Grey 
dots represent individual subject data; red dots represent the overall mean. N.S. = not significant. Cap = capsaicin. N 
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